Nutra Pharma Corp (NPHC) stock
NPHCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $806.69KP/E –Yield –
Nutra Pharma operating margin
Operating margin is operating income as a percentage of revenue.
Nutra Pharma's operating margin for the twelve months ending Jun 30, 2026 was -1017.8%. For fiscal 2025 it was -567.7%, against -356.6% the year before. The highest annual figure on record is -237.2% in fiscal 2010.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -567.7% | −211.0 |
| FY2024 | Dec 31, 2024 | -356.6% | +74.9 |
| FY2023 | Dec 31, 2023 | -431.5% | +876.7 |
| FY2022 | Dec 31, 2022 | -1308.2% | +726.3 |
| FY2021 | Dec 31, 2021 | -2034.5% | −252.3 |
| FY2020 | Dec 31, 2020 | -1782.3% | −604.1 |
| FY2019 | Dec 31, 2019 | -1178.1% | +260.5 |
| FY2018 | Dec 31, 2018 | -1438.7% | −296.4 |
| FY2017 | Dec 31, 2017 | -1142.3% | +71.5 |
| FY2016 | Dec 31, 2016 | -1213.8% | +765.6 |
| FY2015 | Dec 31, 2015 | -1979.4% | −1609.0 |
| FY2014 | Dec 31, 2014 | -370.4% | +1882.1 |
| FY2013 | Dec 31, 2013 | -2252.5% | −973.0 |
| FY2012 | Dec 31, 2012 | -1279.5% | +1195.8 |
| FY2011 | Dec 31, 2011 | -2475.3% | −2238.1 |
| FY2010 | Dec 31, 2010 | -237.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -1263.6% | −919.9 |
| Q1 FY2026 | Mar 31, 2026 | -1391.9% | −919.0 |
| Q4 FY2025 | Dec 31, 2025 | -1614.2% | −1395.7 |
| Q3 FY2025 | Sep 30, 2025 | -506.9% | −260.6 |
| Q2 FY2025 | Jun 30, 2025 | -343.7% | +80.8 |
| Q1 FY2025 | Mar 31, 2025 | -472.9% | +309.8 |
| Q4 FY2024 | Dec 31, 2024 | -218.5% | +79.7 |
| Q3 FY2024 | Sep 30, 2024 | -246.4% | +74.8 |
| Q2 FY2024 | Jun 30, 2024 | -424.5% | −76.5 |
| Q1 FY2024 | Mar 31, 2024 | -782.6% | −51.4 |
| Q4 FY2023 | Dec 31, 2023 | -298.1% | +995.0 |
| Q3 FY2023 | Sep 30, 2023 | -321.2% | +639.4 |
| Q2 FY2023 | Jun 30, 2023 | -347.9% | +851.8 |
| Q1 FY2023 | Mar 31, 2023 | -731.2% | +1510.4 |
| Q4 FY2022 | Dec 31, 2022 | -1293.1% | +616.4 |
| Q3 FY2022 | Sep 30, 2022 | -960.5% | +1698.6 |
| Q2 FY2022 | Jun 30, 2022 | -1199.7% | +240.6 |
| Q1 FY2022 | Mar 31, 2022 | -2241.6% | +215.8 |
| Q4 FY2021 | Dec 31, 2021 | -1909.5% | +432.2 |
| Q3 FY2021 | Sep 30, 2021 | -2659.1% | −1285.0 |
| Q2 FY2021 | Jun 30, 2021 | -1440.3% | +1746.7 |
| Q1 FY2021 | Mar 31, 2021 | -2457.4% | −1364.3 |
| Q4 FY2020 | Dec 31, 2020 | -2341.7% | +1494.6 |
| Q3 FY2020 | Sep 30, 2020 | -1374.2% | −813.7 |
| Q2 FY2020 | Jun 30, 2020 | -3187.1% | +22.4 |
| Q1 FY2020 | Mar 31, 2020 | -1093.2% | −490.7 |
| Q4 FY2019 | Dec 31, 2019 | -3836.3% | −2499.2 |
| Q3 FY2019 | Sep 30, 2019 | -560.5% | +1382.5 |
| Q2 FY2019 | Jun 30, 2019 | -3209.5% | −2066.4 |
| Q1 FY2019 | Mar 31, 2019 | -602.4% | +436.7 |
| Q4 FY2018 | Dec 31, 2018 | -1337.1% | −498.2 |
| Q3 FY2018 | Sep 30, 2018 | -1943.0% | +519.2 |
| Q2 FY2018 | Jun 30, 2018 | -1143.1% | +841.1 |
| Q1 FY2018 | Mar 31, 2018 | -1039.1% | −90.6 |
| Q4 FY2017 | Dec 31, 2017 | -838.9% | – |
| Q1 FY2017 | Mar 31, 2017 | -2462.1% | – |
| Q2 FY2016 | Jun 30, 2016 | -1984.2% | – |
| Q1 FY2016 | Mar 31, 2016 | -948.5% | – |
See a number that looks wrong?